1-isopropyl-3-methyl-8 - (pyridin-2-yl) - 1,3-dihydro-2h-imidazo 4,5-c cinolin-2-one and its use as a selective modulator of telangiectasia (ATM) kinase

摘要

The present invention relates to a novel substituted imidazo [4,5-c] cinolin-2-one compound and a pharmaceutically acceptable salt thereof that selectively regulates a capillary vasodiastolic mutation ("ATM") kinase.The present application also relates to the pharmaceutical composition comprising one or more of the compounds and their salts as active components, and the use of the compounds and their salts in the treatment of ATM related diseases or symptoms involving cancer.No selection